CRM 360 Meeting held on integrated approach to treat type 2 diabetes

AMMAN — Over 300 healthcare professionals from India, the Middle East, and Africa joined international experts to share knowledge and best practice about the importance of taking a multidisciplinary approach to manage type 2 diabetes (T2D) at the ‘CRM 360 Meeting’.

The meeting was hosted by Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, and took place in Dubai on October 21-22.

Key topics included the latest guidelines on treatment adherence, focusing on the burden of chronic kidney disease and cardiovascular disorder associated with type 2 diabetes.

The CRM 360 Meeting was presented by international speakers from Finland and the UK. The meeting was moderated by leading specialists, including Adel El Etriby, Professor of Cardiology at Ain Shams University in Egypt; Khalid Almatham from Saudi Arabia; and Jalal Nafach, American Board-Certified Endocrinologist, University of Nebraska Medical Centre in Nebraska in the US.